Skip to main content
. 2020 Jul 9;8(7):203. doi: 10.3390/biomedicines8070203

Figure 4.

Figure 4

Specific anti-MV130 IgA and IgG antibodies. Prophylaxis with MV130 increases serum IgA antibody production. (A,B) Serum IgA (A) and IgG (B) antibodies against S. pneumoniae (left panels) or the bacterial mixture (right panels), collected from subjects before and after 12 months following MV130 immunotherapy analyzed by ELISA. Data from 6–10 individuals are shown. Lines show paired values. Normal distribution was evaluated using the Shapiro–Wilk test. p values were calculated using Paired Student’s t-test or Wilcoxon signed-rank test.